Results 181 to 190 of about 926,237 (299)
Burkholderia cepacia complex in septicaemic non-cystic fibrosis cases from two tertiary care hospitals in north India [PDF]
, 2010 Arora, Anita, Bansal, Deepak, Das, Anindita, Garg, RK, Gautam, Vikas, Koushal, Vipin, Madhup, SK, Marwaha, RK, Rana, Sudesh, Ray, Pallab, Sharma, Kusum, Sharma, Meera, Vandamme, Peter +12 morecore +2 more sourcesPopulation pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir–ritonavir in patients with COVID‐19
British Journal of Clinical Pharmacology, EarlyView.Aims
The repurposed use of favipiravir in COVID‐19 has been reported to have limited clinical efficacy, yet it has been widely used in some countries. Favipiravir causes mutagenesis in RNA viruses, and it is currently unknown whether it may have a measurable effect on the virus in humans.Akosua A. Agyeman, Laura Buggiotti, Li‐An K. Brown, Jose A. Guerra‐Assuncao, Japhette E. Kembou‐Ringert, Wen Y. Mak, Judith Breuer, David M. Lowe, Joseph F. Standing, FLARE Investigators +9 morewiley +1 more sourceTherapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study
British Journal of Clinical Pharmacology, EarlyView.Aims
Paediatric pharmacokinetics differ significantly from adults due to age‐related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited.Gianluca Gazzaniga, Stefano Agliardi, Riccardo Giossi, Alice Schianchi, Alessandra Romandini, Thomas Virdis, Silvia Nerini Molteni, Maria Luisa De Angelis, Stefania Paccagnini, Cecilia Gechtman, Alice Proto, Marco Fossati, Silvia Oliveri, Giulia Angela Pattarino, Elena Altieri, Agnese Graziosi, Arianna Pani, Romano Danesi, Stefano Martinelli, Costantino De Giacomo, Francesco Scaglione +20 morewiley +1 more sourcePredictors for Publication of Specialty Theses in the Field of Infectious Diseases and Clinical Microbiology. [PDF]
Infect Dis Clin Microbiolİrkören P, Agüloğlu-Bali E, Usta O, Şenol A, Manavlı B, Tanır B, Gürbüz E, Araz H, Alıravcı ID, Can İN, Demir-Önder K, Coşkunpınar-Törüyenler M, Deniz M, Boran R, Mızrakçı S, Akıl ŞS, Pala-Karakök T, Tüzün T, Çakır-Kıymaz Y, Ürkmez-Korkmaz FY, Uygun-Kızmaz Y, Özger S, Ergönül Ö. +22 moreeuropepmc +1 more sourceRBD‐SD1 Nanoparticle Vaccines From DPP4‐Using Merbecoviruses Elicit a Cross‐Reactive Antibody Response but Limited Cross‐Protective Immunity
Biotechnology and Bioengineering, EarlyView.SpyCatcher‐mi3 nanoparticles displaying RBD‐SD1 from MERS‐CoV, NL140422, and HKU4 elicited robust and cross‐reactive IgG responses in mice. Only MERS‐CoV RBD‐SD1 induced neutralizing antibodies against MERS‐CoV and protected human DPP4 mice from a MERS‐CoV challenge, indicating conserved serologic but limited cross‐neutralizing epitopes.Peter J. Halfmann, Jeong Soo Lee, Tong Wang, Augustine Duffy, Janie E. Rogers, Natasha Chen, Elizabeth Frimpong, Carmen Rai, Yoshihiro Kawaoka, Ravi S. Kane +9 morewiley +1 more sourceBarriers and perceptions of WHONET/BacLink adoption in Nepal: A qualitative study of clinical microbiology laboratories. [PDF]
PLoS OneMaharjan S, Gallagher P, Gautam M, Gautam S, Budhathoki M, Mukhiya R, Kattel S, Bhandari A, Joh HS, Aboushady AT, Zellweger RM, Upadhyaya MK, Jha R, Acharya J, MacWright WR, Marks F, Stelling J, Poudyal N. +17 moreeuropepmc +1 more sourceA thorn injury, a sea‐borne culprit, and a tenosynovitis dilemma
Arthritis &Rheumatology, Accepted Article.Jacopo Ciaffi, Francesco Mori, Paolo Sassu, Marco Gambarotti, Alberto Righi, Eleonora Zamparini, Marco Innocenti, Marina Tadolini, Francesco Ursini +8 morewiley +1 more source